We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $375M
1-Year Est. Return 131.24%
This Fund
S&P 500
This Quarter Est. Return
+13.22%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$18.4M
Cap. Flow
+$7.78M
Cap. Flow %
7.34%
Top 10 Hldgs %
47.47%
Holding
62
New
7
Increased
12
Reduced
31
Closed
8

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.93M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.44M
3
AMGN icon
Amgen
AMGN
+$3.13M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.45M
5
LLY icon
Eli Lilly
LLY
+$1.45M

Top Sells

Rank Stock Value
1
BTT icon
BlackRock Municipal 2030 Target Term Trust
BTT
+$2.59M
2
AMT icon
American Tower
AMT
+$1.59M
3
UNH icon
UnitedHealth
UNH
+$937K
4
CVX icon
Chevron
CVX
+$636K
5
TMO icon
Thermo Fisher Scientific
TMO
+$595K

Sector Composition

Rank Sector Weight
1 Healthcare 26.81%
2 Energy 19.37%
3 Miscellaneous 18.37%
4 Consumer Staples 14.5%
5 Industrials 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$1.51M 1.42%
3,941
-194
-5% -$74.6K
LLY icon
27
Eli Lilly
LLY
$994B
$1.5M 1.41%
+4,090
New +$1.45M
MPLX icon
28
MPLX
MPLX
$60.7B
$1.31M 1.24%
40,000
– –
NOC icon
29
Northrop Grumman
NOC
$73.7B
$1.17M 1.1%
+2,138
New +$1.12M
AZN icon
30
AstraZeneca
AZN
$248B
$1.15M 1.08%
8,455
-2,632
-24% -$330K
EPD icon
31
Enterprise Products Partners
EPD
$84B
$965K 0.91%
40,000
– –
MCD icon
32
McDonald's
MCD
$179B
$939K 0.89%
3,562
+253
+8% +$66.7K
XOM icon
33
ExxonMobil
XOM
$683B
$907K 0.86%
8,227
-848
-9% -$90.9K
KMI icon
34
Kinder Morgan
KMI
$68.7B
$729K 0.69%
40,317
+483
+1% +$8.69K
GLD icon
35
SPDR Gold Trust
GLD
$147B
$697K 0.66%
+4,110
New +$662K
JNJ icon
36
Johnson & Johnson
JNJ
$640B
$679K 0.64%
3,844
-25
-0.6% -$4.32K
IBDQ
37
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$558K 0.53%
22,924
-759
-3% -$18.4K
GIS icon
38
General Mills
GIS
$19.2B
$533K 0.5%
6,354
-225
-3% -$18.3K
WM icon
39
Waste Management
WM
$85.3B
$533K 0.5%
3,395
-155
-4% -$24.9K
COP icon
40
ConocoPhillips
COP
$165B
$522K 0.49%
4,420
-597
-12% -$72.6K
IBM icon
41
IBM
IBM
$229B
$514K 0.49%
3,650
-160
-4% -$22.1K
V icon
42
Visa
V
$692B
$494K 0.47%
2,376
-35
-1% -$7.06K
DE icon
43
Deere & Co
DE
$182B
$431K 0.41%
1,005
– –
CCI icon
44
Crown Castle
CCI
$32.2B
$396K 0.37%
2,920
-453
-13% -$61.3K
AAPL icon
45
Apple
AAPL
$4.85T
$391K 0.37%
3,006
-724
-19% -$103K
GDXJ icon
46
VanEck Junior Gold Miners ETF
GDXJ
$9.32B
$357K 0.34%
+10,000
New +$329K
MA icon
47
Mastercard
MA
$499B
$335K 0.32%
962
-11
-1% -$3.62K
IWF icon
48
iShares Russell 1000 Growth ETF
IWF
$125B
$318K 0.3%
5,940
-164
-3% -$9.02K
NKE icon
49
Nike
NKE
$54.6B
$316K 0.3%
2,703
-4,893
-64% -$493K
PHYS icon
50
Sprott Physical Gold
PHYS
$15.6B
$314K 0.3%
+22,300
New +$298K
1
2
3

Similar funds

PCM
Payne Capital Management New York $375M AUM 22.8% 1-Year Est. Return
FLI
Family Legacy Inc Greenville, South Carolina $375M AUM 35.98% 1-Year Est. Return
CCM
Consolidated Capital Management Burbank, California $375M AUM 54.27% 1-Year Est. Return
SBF
Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return
SPFSPD
Sava Pension Fund (Sava Penzisko Drushtvo) Skopje $375M AUM 25.78% 1-Year Est. Return
HIC
Harbor Island Capital Topsfield, Massachusetts $376M AUM 128.24% 1-Year Est. Return
WIC
WealthBridge Investment Counsel Calgary, Alberta, Canada $375M AUM 37.9% 1-Year Est. Return
BAM
Bell Asset Management Melbourne, Australia $375M AUM 3.54% 1-Year Est. Return

Geneva Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Geneva Partners held 62 positions worth $106M, up 21% from $87.5M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Geneva Partners deployed $7.78M of net new capital in Q4 2022, opening 7 new positions and adding to 12 existing holdings. Its largest new stake was Eli Lilly: 4,090 shares worth $1.5M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Energy and Miscellaneous.

On the sell side, the largest reduction was UnitedHealth, an estimated $937K trimmed.

  • Geneva Partners's largest Q4 2022 buy was Eli Lilly: 4,090 shares worth $1.5M.
  • Geneva Partners added most to Merck in Q4 2022, an estimated $4.93M increase.
  • Geneva Partners's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $937K.
  • Geneva Partners fully exited BlackRock Municipal 2030 Target Term Trust in Q4 2022, selling an estimated $2.59M.
  • Geneva Partners's ten largest holdings make up 47% of its $106M portfolio in Q4 2022.
  • Geneva Partners opened 7 new positions and closed 8 in Q4 2022.
  • Geneva Partners's portfolio value rose 21% quarter-over-quarter to $106M.

Based on Geneva Partners's 13F filing for Q4 2022, filed 23 Jan 2023.